Remsima 120 mg solution for injection in pre-filled syringe

DRUG2 trials

Sponsors

Centre Medico Chirurgical Ambroise Pare Hartmann, Sint Maartenskliniek Stichting

Conditions

Immune Bowel Disease (including Crohn's disease and Ulcerative colitis).Rheumatoid arthritis

Phase 3

Pharmacokinetics, Efficacy and Safety of CT-P13 Subcutaneous as Induction Therapy in Patients with Active Crohn’s Disease or Ulcerative Colitis

CompletedCTIS2023-508584-72-00

Centre Medico Chirurgical Ambroise Pare HartmannImmune Bowel Disease (including Crohn's disease and Ulcerative colitis).

Start: 2024-07-10End: 2025-05-14Target: 130Updated: 2024-07-30

Phase 4

DISCO-RA:DIScontinuation of COncomitant disease modifying anti-rheumatic drugs (DMARDs) in rheumatoid arthritis patients also using TNF inhibitors - a randomized long-term non-inferiority strategy trial

Not yet recruitingCTIS2026-525316-33-00

Sint Maartenskliniek StichtingRheumatoid arthritis

Target: 202Updated: 2026-06-09